EUVIMEDEUVIMED entdecken
CrossrefInfokarte

iRAPA CrossMark Policy

Managing Editor iRAPA

Biomedicine and Chemical Sciences · 2022

DOI: 10.48112/bcs.v1i1.328 ↗
AbstractBibliografische Angaben

Abstract

CrossMark is a multi-publisher initiative to provide a standard way for readers to locate the authoritative version of an article or other published content. By applying the CrossMark logo, Springer is committing to maintaining the content it publishes and to alerting readers to changes if and when they occur. Clicking the CrossMark logo on a document will tell you its current status and may also give you additional publication-record information about the document. For more information on CrossMark, please visit the CrossMark site. The iRAPA content that will have the CrossMark logo is restricted to current and future journal content and is limited to specific publication types. For general author guidelines and information, please see: Authors' Guidelines. Correction and Retraction Policies iRAPA is committed to uphold the integrity of the literature and publishes Errata, Expressions of Concerns or Retraction Notices dependent on the situation and in accordance with the COPE Retraction Guidelines. In all cases, these notices are linked to the original article. More information on iRAPA’s guidelines can be found here: Publication Ethics Information on COPE Retraction Guidelines can be found here: Retraction Guidelines

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →